Global support for a quality solution
We lead innovation in peptide API’s to the benefit of millions of patients
Contact usCEO Raymond De Vré, presented at the Jefferies Healthcare Conference
15 November, London
See Presentation"We are proud to support our customers to the benefit of millions of patients"
<2 minutes with Raymond De Vré, CEO
watch the videoAhead on green peptide chemistry
Together we improve process performance while reducing the environmental footprint
Learn moreMarket leader in peptide API manufacturing and services
PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API).
FluoGuide reaches milestone with FG001 for phase III clinical supply
9 Nov 2022 - Copenhagen, Denmark, 8 November 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to inform that the first large scale batch for its lead product […]
Read morePolyPeptide with encouraging progress within custom projects pipeline – however with lower profitability in the first half of 2022
19 Aug 2022 - Baar, 19 August 2022 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligo-nucleotide-based active pharmaceutical ingredients, today announced its detailed results […]
Read more